View Agent
| Agent Info | |
| Agent: | obatoclax |
| Synonyms: | GX15-070,obatoclax mesylate |
| Drug Status For Certain Diseases: | Solid tumours(phase II) |
| Classification: | proapoptotic small-molecule pan-Bcl-2 inhibitor |
| Target: | Apoptosis regulator Bcl-X Apoptosis regulator Bcl-2 Induced myeloid leukemia cell differentiation protein Mcl-1 |
| KEGG Pathway: | Colorectal cancer Pathways in cancer Small cell lung cancer Hepatitis B MicroRNAs in cancer Sphingolipid signaling pathway Tuberculosis Toxoplasmosis PI3K-Akt signaling pathway Prostate cancer Apoptosis Protein processing in endoplasmic reticulum HIF-1 signaling pathway Epstein-Barr virus infection Amyotrophic lateral sclerosis (ALS) |
| Wiki Pathway: | miR-targeted genes in lymphocytes - TarBase DNA Damage Response (only ATM dependent) Interleukin-11 Signaling Pathway Prostate Cancer Corticotropin-releasing hormone Nanoparticle triggered autophagic cell death Intrinsic Pathway for Apoptosis IL-2 Signaling Pathway Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways Integrated Pancreatic Cancer Pathway IL-5 Signaling Pathway TP53 Network Kit receptor signaling pathway miR-targeted genes in leukocytes - TarBase IL-3 Signaling Pathway miR-targeted genes in muscle cell - TarBase Integrated Breast Cancer Pathway Influenza A virus infection Amyotrophic lateral sclerosis (ALS) Senescence and Autophagy in Cancer Apoptosis Modulation and Signaling Apoptosis FAS pathway and Stress induction of HSP regulation Integrated Cancer pathway Focal Adhesion |